Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
TCI GLP-1
- Development stage
- Unknown
- Lead developer
- TCI
- Modality
- Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
TCI GLP-1 is a natural dietary supplement developed by TCI Co., Ltd. that functions as an endogenous glucagon-like peptide-1 (GLP-1) secretagogue. The formula is composed of a synergistic blend of plant extracts, probiotics, prebiotics, and amino acids, including phenylalanine and leucine, which work together to stimulate GLP-1 release from intestinal L-cells. By increasing natural GLP-1 levels, the supplement helps regulate appetite, promote satiety, and support weight management. Clinical data indicates that the formula also contributes to fat metabolism, blood glucose stabilization, and cholesterol reduction. It is available in oral formats such as tablets, liquids, and powder sachets.
- Brand names
- TCI GLP-1
- Other names
- TCI GLP-1 Formula
02
Targets
GLP1R (GLP-1R)GLP-1 (Glucagon-like peptide-1)
Beyond the preview
Go deeper on TCI GLP-1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TCI GLP-1.